Reading room

Terapia January 2022 NR 1 ( 408 )

Clinical manifestations in long-COVID and post-COVID syndromes

Editor of the issue: dr hab. n. med. Tomasz Dzieciątkowski

Contents:

Two years of SARS-CoV-2 menance

    Authors:
  • dr hab. n. med. Tomasz Dzieciątkowski
Keywords: telemedicine, primary health, coronavirus, pandemic

COVID-19 immunology – facts, doubts and challenges

    Authors:
  • dr n. wet. Anna Golke
Keywords: SARS-CoV-2, COVID-19, immune response, infection

Current recommendations for virological diagnosis of COVID-19, long-COVID and post-COVID syndromes

    Authors:
  • dr hab. n. med. Tomasz Dzieciątkowski
Keywords: SARS-CoV-2, COVID-19, laboratory diagnostics

Clinical manifestations of long-COVID syndrome in a pediatric population

    Authors:
  • dr hab. n. med. Ernest Kuchar
Keywords: coronavirus disease, COVID-19 complications, chronic fatigue syndrome, MIS-C, sequelae, post-COVID syndrome

Psychiatric aspects of the COVID-19 pandemic

    Authors:
  • dr n. med. Piotr Wierzbiński
Keywords: depression, COVID-19, stress, immunology

Long term respiratory effects of COVID-19

    Authors:
  • prof. dr hab. n. med. Piotr Kuna
Keywords: COVID-19, lungs, respiratory failure, post covid, long COVID, budesonide

Neurological complications in post-COVID syndrome

    Authors:
  • lek. Stanisław Słyk
  • dr hab. n. med. Izabela Domitrz
Keywords: post-COVID, long-COVID, SARS-CoV-2, neurological complications, coronavirus

COVID-19 and acute kidney injury

    Authors:
  • prof. dr hab. n. med. Joanna Matuszkiewicz-Rowińska
  • prof. dr hab. n. med. Jolanta Małyszko
Keywords: COVID-19, SARS-CoV-2, acute kidney injury, glomerulonephritis, renal replacement therapy

COVID-19 therapeutic options

    Authors:
  • prof. dr hab. n. med. Krzysztof Tomasiewicz
Keywords: SARS-CoV-2, COVID-19, therapy, remdesivir, monoclonal antibodies, anti-cytokine medication

Pulmonary rehabilitation after COVID-19

    Authors:
  • dr hab. n. med. Adam J. Białas, prof. UM
  • prof. dr hab. n. med. Piotr Kuna
Keywords: COVID-19, rehabilitation

Potential in vitro efficacy of cetylpyridinium chloride against SARS-CoV-2

    Authors:
  • dr hab. n. med. Tomasz Dzieciątkowski
Keywords: coronavirus, SARS-CoV-2, COVID-19, cetylpyridinium chloride